These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30518364)

  • 1. Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea.
    Kim J; Lee HS; Lee KY
    Cardiovasc Diabetol; 2018 Dec; 17(1):155. PubMed ID: 30518364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H; Brugts J; Ades T
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.
    Zhang X; Xing L; Jia X; Pang X; Xiang Q; Zhao X; Ma L; Liu Z; Hu K; Wang Z; Cui Y
    Cardiovasc Ther; 2020; 2020():3987065. PubMed ID: 32411300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
    Na E; Cho S; Kim DJ; Choi J; Han E
    Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and new-onset diabetes: a retrospective longitudinal cohort study.
    Ma T; Tien L; Fang CL; Liou YS; Jong GP
    Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.
    Casula M; Mozzanica F; Scotti L; Tragni E; Pirillo A; Corrao G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):396-406. PubMed ID: 28416099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Kurogi K; Michishita I; Nozue T; Sugiyama S; Tsimikas S; Yoshida H; Ray KK
    Atherosclerosis; 2015 Aug; 241(2):409-18. PubMed ID: 26074315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS).
    Zhang J; Shao Y; Liu Y; Tao J
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):581-589. PubMed ID: 30187345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
    Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
    Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do statins beneficially or adversely affect glucose homeostasis?
    Kostapanos MS; Liamis GL; Milionis HJ; Elisaf MS
    Curr Vasc Pharmacol; 2010 Sep; 8(5):612-31. PubMed ID: 20507274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome.
    Bener A; Dogan M; Barakat L; Al-Hamaq AO
    J Prim Care Community Health; 2014 Jul; 5(3):180-7. PubMed ID: 24522932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins Are Associated With Increased Insulin Resistance and Secretion.
    Abbasi F; Lamendola C; Harris CS; Harris V; Tsai MS; Tripathi P; Abbas F; Reaven GM; Reaven PD; Snyder MP; Kim SH; Knowles JW
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2786-2797. PubMed ID: 34433298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients.
    Sukhija R; Prayaga S; Marashdeh M; Bursac Z; Kakar P; Bansal D; Sachdeva R; Kesan SH; Mehta JL
    J Investig Med; 2009 Mar; 57(3):495-9. PubMed ID: 19188844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.
    Lee HY; Cho HJ; Kim HY; Jeon HK; Shin JH; Kang SM; Baek SH
    Korean J Intern Med; 2014 Nov; 29(6):754-63. PubMed ID: 25378974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.
    Arnaboldi L; Corsini A
    Atheroscler Suppl; 2015 Jan; 16():1-27. PubMed ID: 25575403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin diabetogenicity: guidance for clinicians.
    Ray K
    Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S3. PubMed ID: 23819776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.
    Toth PP; Catapano AL; Farnier M; Foody J; Tomassini JE; Jensen E; Polis AB; Hanson ME; Musliner TA; Tershakovec AM
    Am J Cardiol; 2016 Dec; 118(12):1812-1820. PubMed ID: 27756478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.